+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Biomarker Type (Predictive, Prognostic), By Therapeutic Area (Oncology, Neurology, Autoimmune Diseases), By Phase, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899620
Description Jump to:
The global biomarker discovery outsourcing services market size is expected to reach USD 49.32 billion by 2030, growing at a CAGR of 21.1% during the forecast period. The expansion of outsourced biomarker research, attributed to the increased utilization of biomarkers in clinical trials and the accelerating level of outsourcing undertaken by pharmaceutical firms are key growth factors for this market.

Furthermore, increasing adoption of liquid biopsies is expected to drive the market growth. Liquid biopsies, which involve the analysis of biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid, offer several advantages over traditional tissue biopsies, such as being less invasive and providing real-time information. As a result, the adoption of liquid biopsies has been growing rapidly, and this trend directly impacts the demand for biomarker discovery outsourcing services.

Advancements in omics technologies are expected to drive market growth in the coming years. Progress in genomics, proteomics, metabolomics, and other omics technologies has enabled the identification of novel biomarkers. Integrating data from many omics disciplines can often be advantageous for biomarker identification. This all-encompassing approach enables a more thorough comprehension of complex disorders and can result in identifying reliable, multidimensional biomarkers. Outsourcing services specializing in multi-omics data integration offer valuable expertise in this area.

An increase in drug development and clinical trials is a major contributing factor to the market growth. Biomarkers play a crucial role in drug development, helping pharmaceutical companies identify suitable drug targets, streamline clinical trial processes, and select patient populations for trials. As of 2023, the global clinical trial landscape boasts 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This reflects a notable surge compared to the roughly 365,000 registered trials documented in early 2021, underscoring the robust and ongoing growth within the field of clinical research.

Biomarker Discovery Outsourcing Services Market Report Highlights

  • Based on type, the surrogate endpoints segment held the largest share in 2022. Surrogate biomarkers can provide a more precise understanding of a drug's mechanism of action, allowing for targeted therapies and personalized medicine approaches
  • The predictive biomarkers segment is expected to show significant market share in the coming years. In clinical trials, patient categorization depends on predictive biomarkers
  • In the therapeutic area segment, oncology dominated the market in 2022, accounting for over 34% of the total revenue. The key factors contributing to the growth include the high incidence of cancer, personalized medicine in oncology, and increased drug development in oncology
  • The autoimmune diseases segment is expected to show significant market share in the coming years. This is attributed to the advancements in omics technologies, biomarker-driven drug development, and the introduction of emerging therapies
  • Based on the discovery phase segment, biomarker identification held a major revenue share of over 28% in 2022 due to wide applications of biomarker identifications in drug discovery and development. Pharmaceutical and biotechnology companies heavily rely on biomarker identification to advance their research and development efforts


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.5. Market Driver Analysis
3.6. Market Restraint Analysis
3.7. Business Environment Analysis
3.7.1. SWOT Analysis
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Biomarker Discovery Outsourcing Services Market: Type Movement Analysis
4.2. Predictive biomarkers
4.2.1. Predictive biomarkers Market, 2018 - 2030 (USD Billion)
4.3. Prognostic biomarkers
4.3.1. Prognostic Biomarkers Market, 2018 - 2030 (USD Billion)
4.4. Safety biomarkers
4.4.1. Safety Biomarkers Market, 2018 - 2030 (USD Billion)
4.5. Surrogate endpoints
4.5.1. Surrogate endpoints Market, 2018 - 2030 (USD Billion)
Chapter 5. Therapeutic Area Business Analysis
5.1. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Movement Analysis
5.2. Oncology
5.2.1. Oncology Market, 2018 - 2030 (USD Billion)
5.3. Neurology
5.3.1. Neurology Market, 2018 - 2030 (USD Billion)
5.4. Cardiology
5.4.1. Cardiology Market, 2018 - 2030 (USD Billion)
5.5. Autoimmune Diseases
5.5.1. Autoimmune Diseases Market, 2018 - 2030 (USD Billion)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 6. Discovery Phase Business Analysis
6.1. Biomarker Discovery Outsourcing Services Market: Discovery Phase Movement Analysis
6.2. Biomarker Identification
6.2.1. Biomarker Identification Market, 2018 - 2030 (USD Billion)
6.3. Biomarker Validation
6.3.1. Biomarker Validation Market, 2018 - 2030 (USD Billion)
6.4. Biomarker Profiling
6.4.1. Biomarker Profiling Market, 2018 - 2030 (USD Billion)
6.5. Biomarker Panel Development
6.5.1. Biomarker Panel Development Market, 2018 - 2030 (USD Billion)
6.6. Biomarker Selection
6.6.1. Biomarker Selection Market, 2018 - 2030 (USD Billion)
Chapter 7. End-use end-use Business Analysis
7.1. Biomarker Discovery Outsourcing Services Market: end-use Movement Analysis
7.2. Pharmaceutical Companies
7.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Billion)
7.3. Biotechnology Companies
7.3.1. Biotechnology Companies Market, 2018 - 2030 (USD Billion)
7.4. Others
7.4.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 8. Regional Business Analysis
8.1. Biomarker Discovery Outsourcing Services Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Framework
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Framework
8.2.3.3. Competitive Scenario
8.2.3.4. Canada Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3. Europe
8.3.1. Europe Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. UK Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Germany Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. France Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Italy Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Spain Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Sweden Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.8. Norway
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Norway Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.3.9. Denmark
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Denmark Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Japan Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. China Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. India Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Australia Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. South Korea Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Thailand Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Brazil Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Mexico Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Argentina Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.6. MEA
8.6.1. MEA Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. South Africa Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Saudi Arabia Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. UAE Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Kuwait Biomarker Discovery Outsourcing Services Market, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Merger& Acquisition
9.2.2. Collaborations
9.2.3. New Product Launch
9.3. Participant’s overview
9.3.1. Laboratory Corporation of America Holdings
9.3.1.1. Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Charles River Laboratories
9.3.2.1. Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Eurofins Scientific
9.3.3.1. Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Celerion
9.3.4.1. Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. ICON plc
9.3.5.1. Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Parexel International (MA) Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Proteome Sciences
9.3.7.1. Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. GHO Capital
9.3.8.1. Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Thermo Fisher Scientific Inc
9.3.9.1. Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Evotec
9.3.10.1. Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 4. Global Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 5. Global Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 6. Global Biomarker Discovery Outsourcing Services Market by end-use, 2018-2030 (USD Billion)
Table 7. Global Biomarker Discovery Outsourcing Services Market by Region, 2018-2030 (USD Billion)
Table 8. North America Biomarker Discovery Outsourcing Services Market by Country, 2018-2030 (USD Billion)
Table 9. North America Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 10. North America Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 11. North America Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 12. North America Biomarker Discovery Outsourcing Services Market by end-use, 2018-2030 (USD Billion)
Table 13. U.S. Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 14. U.S. Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 15. U.S. Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 16. U.S. Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 17. Canada Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 18. Canada Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 19. Canada Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 20. Canada Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 21. Europe Biomarker Discovery Outsourcing Services Market by Country, 2018-2030 (USD Billion)
Table 22. Europe Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 23. Europe Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 24. Europe Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 25. Europe Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 26. Germany Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 27. Germany Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 28. Germany Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 29. Germany Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 30. UK Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 31. UK Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 32. UK Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 33. UK Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 34. France Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 35. France Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 36. France Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 37. France Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 38. Italy Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 39. Italy Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 40. Italy Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 41. Italy Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 42. Spain Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 43. Spain Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 44. Spain Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 45. Spain Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 46. Denmark Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 47. Denmark Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 48. Denmark Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 49. Denmark Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 50. Sweden Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 51. Sweden Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 52. Sweden Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 53. Sweden Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 54. Norway Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 55. Norway Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 56. Norway Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 57. Norway Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 58. Asia Pacific Biomarker Discovery Outsourcing Services Market by Country, 2018-2030 (USD Billion)
Table 59. Asia Pacific Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 60. Asia Pacific Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 61. Asia Pacific Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 62. Asia Pacific Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 63. China Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 64. China Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 65. China Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 66. China Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 67. Japan Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 68. Japan Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 69. Japan Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 70. Japan Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 71. India Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 72. India Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 73. India Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 74. India Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 75. South Korea Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 76. South Korea Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 77. South Korea Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 78. South Korea Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 79. Australia Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 80. Australia Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 81. Australia Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 82. Australia Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 83. Thailand Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 84. Thailand Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 85. Thailand Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 86. Thailand Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 87. Latin America Biomarker Discovery Outsourcing Services Market by Country, 2018-2030 (USD Billion)
Table 88. Latin America Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 89. Latin America Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 90. Latin America Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 91. Latin America Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 92. Brazil Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 93. Brazil Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 94. Brazil Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 95. Brazil Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 96. Mexico Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 97. Mexico Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 98. Mexico Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 99. Mexico Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 100. Argentina Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 101. Argentina Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 102. Argentina Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 103. Argentina Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 104. Middle East & Africa Biomarker Discovery Outsourcing Services Market by Country, 2018-2030 (USD Billion)
Table 105. Middle East & Africa Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 106. Middle East & Africa Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 107. Middle East & Africa Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 108. Middle East & Africa Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 109. South Africa Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 110. South Africa Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 111. South Africa Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 112. South Africa Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 113. Saudi Arabia Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 114. Saudi Arabia Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 115. Saudi Arabia Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 116. Saudi Arabia Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 117. UAE Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 118. UAE Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 119. UAE Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 120. UAE Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
Table 121. Kuwait Biomarker Discovery Outsourcing Services Market by Type, 2018-2030 (USD Billion)
Table 122. Kuwait Biomarker Discovery Outsourcing Services Market by Therapeutic Area, 2018-2030 (USD Billion)
Table 123. Kuwait Biomarker Discovery Outsourcing Services Market by Discovery Phase, 2018-2030 (USD Billion)
Table 124. Kuwait Biomarker Discovery Outsourcing Services Market by End-use, 2018-2030 (USD Billion)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Biomarker Discovery Outsourcing Services Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Biomarker Discovery Outsourcing Services Market for Predictive biomarkers, 2018-2030 (USD Billion)
Fig. 16 Global Biomarker Discovery Outsourcing Services Market for Prognostic biomarkers, 2018-2030 (USD Billion)
Fig. 17 Global Biomarker Discovery Outsourcing Services Market for Safety biomarkers, 2018-2030 (USD Billion)
Fig. 18 Global Biomarker Discovery Outsourcing Services Market for Surrogate endpoints, 2018-2030 (USD Billion)
Fig. 19 Global Biomarker Discovery Outsourcing Services Market for Oncology, 2018-2030 (USD Billion)
Fig. 20 Global Biomarker Discovery Outsourcing Services Market for Neurology, 2018-2030 (USD Billion)
Fig. 21 Global Biomarker Discovery Outsourcing Services Market for Cardiology, 2018-2030 (USD Billion)
Fig. 22 Global Biomarker Discovery Outsourcing Services Market for Autoimmune Diseases, 2018-2030 (USD Billion)
Fig. 23 Global Biomarker Discovery Outsourcing Services Market for Others
Fig. 24 Global Biomarker Discovery Outsourcing Services Market for Biomarker Identification
Fig. 25 Global Biomarker Discovery Outsourcing Services Market for Biomarker Validation
Fig. 26 Global Biomarker Discovery Outsourcing Services Market for Biomarker Profiling
Fig. 27 Global Biomarker Discovery Outsourcing Services Market for Biomarker Panel Development
Fig. 28 Global Biomarker Discovery Outsourcing Services Market for Biomarker Selection
Fig. 29 Global Biomarker Discovery Outsourcing Services Market for Pharmaceutical Companies
Fig. 30 Global Biomarker Discovery Outsourcing Services Market for Biotechnology Companies
Fig. 31 Global Biomarker Discovery Outsourcing Services Market for Others
Fig. 32 Regional Outlook, 2021 & 2030
Fig. 33 North America Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 34 U.S. Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 35 Canada Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 36 Europe Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 37 Germany Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 38 UK Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 39 France Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 40 Italy Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 41 Spain Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 42 Denmark Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 43 Sweden Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 44 Norway Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 45 Asia Pacific Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 46 Japan Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 47 China Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 48 India Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 49 Australia Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 50 South Korea Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 51 Thailand Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 52 Latin America Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 53 Brazil Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 54 Mexico Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 55 Argentina Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 56 Middle East and Africa Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 57 South Africa Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 58 Saudi Arabia Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 59 UAE Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)
Fig. 60 Kuwait Biomarker Discovery Outsourcing Services Market 2018-2030 (USD Billion)

Companies Mentioned

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories
  • Eurofins Scientific
  • Celerion
  • ICON plc
  • Parexel International (MA) Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc
  • Evotec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 10.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 49.32 Billion
Compound Annual Growth Rate21.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Biomarker Clinical Phase Outsourcing Services Market Size, Share & Trends Analysis Report By Biomarker Type (Predictive Biomarkers, Surrogate Endpoints), By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Biomarker Clinical Phase Outsourcing Services Market Size, Share & Trends Analysis Report By Biomarker Type (Predictive Biomarkers, Surrogate Endpoints), By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 195 Pages
  • Global
From
Global Biomarker Clinical Phase Outsourcing Services Market Analysis & Forecast to 2024-2034 - Product Image

Global Biomarker Clinical Phase Outsourcing Services Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Global Biomarkers Market Size, Share & Trends Analysis Report by Type (Efficacy, Validation), Product, Application (Drug Discovery & Development, Personalized Medicine), Disease, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Biomarkers Market Size, Share & Trends Analysis Report by Type (Efficacy, Validation), Product, Application (Drug Discovery & Development, Personalized Medicine), Disease, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Global Biomarkers Market by Type, Disease, Application - Industry Analysis, Trends, Growth, Segment Forecasts, and Regional Outlook - Forecast to 2030 - Product Image

Global Biomarkers Market by Type, Disease, Application - Industry Analysis, Trends, Growth, Segment Forecasts, and Regional Outlook - Forecast to 2030

  • Report
  • 76 Pages
  • Global
From
Clinical Biomarkers Market - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology, End User, and Region - Analysis and Forecast, 2023-2033 - Product Image

Clinical Biomarkers Market - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology, End User, and Region - Analysis and Forecast, 2023-2033

  • Report
  • 255 Pages
  • Global
From

About the Biomarker Discovery Market

Biomarker Discovery is a field of research that focuses on the identification and characterization of biomarkers, which are biological molecules that can be used to measure and monitor the progression of a disease or condition. Biomarkers can be used to diagnose, predict, and monitor the effectiveness of treatments. They can also be used to identify individuals at risk of developing a disease or condition. Biomarker Discovery is a rapidly growing field, with many companies investing in research and development. Companies such as Illumina, Qiagen, and Thermo Fisher Scientific are leading the way in developing new technologies and products for biomarker discovery. Other companies such as Roche, Abbott, and Agilent Technologies are also investing in biomarker discovery, offering a range of products and services. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.